Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: Amgen
Solid Tumors
United States, Argentina, Australia, Austria, Belgium +21 more
Sponsor: Sanofi
Crohn's Disease
United States, Canada, Georgia, Japan, Moldova +2 more
- Samtasu Post-marketing General Drug Use-results Survey in Patients With Volume Overload in Heart Failure.Active Not Recruiting
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Heart Failure
Japan
- Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are ClosingActive Not Recruiting
Sponsor: Pfizer
Advanced Malignancies · NSCLC · Ovarian Cancer · Urothelial Cancer
United States, Australia, Belgium, Canada, Denmark +14 more
Sponsor: Bayer
Chronic Kidney Disease · Type 2 Diabetes Mellitus
United States, Germany, Japan, Taiwan
Sponsor: Eli Lilly and Company
Alzheimer Disease
United States, Japan
Sponsor: Hoffmann-La Roche
Carcinoma, Hepatocellular
United States, Australia, Austria, Belgium, Brazil +21 more
- Digital Phenotyping of High-Risk Chronic Ventilator-Dependent PatientsEnrolling By Invitation
Sponsor: China-Japan Friendship Hospital
Ventilator Dependency
China
Sponsor: Alexion Pharmaceuticals, Inc.
Thrombotic Microangiopathy
United States, Australia, Belgium, Brazil, Canada +12 more
Sponsor: Alexion Pharmaceuticals, Inc.
Delayed Graft Function · DGF · Kidney Transplant
United States, Argentina, Australia, Austria, Brazil +13 more
Sponsor: Eli Lilly and Company
Ovarian Neoplasms · Endometrial Neoplasms · Uterine Cervical Neoplasms · Carcinoma, Non-Small-Cell Lung
United States, Australia, France, Italy, Japan +2 more
- A Study to Learn More About How Safe Darolutamide is Under Real-world Conditions in Participants With Metastatic Hormone-Sensitive Prostate CancerActive Not Recruiting
Sponsor: Bayer
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Japan
Sponsor: Alexion Pharmaceuticals, Inc.
Neuromyelitis Optica Spectrum Disorder · NMOSD · AQP4+ NMOSD
United States, Argentina, Canada, China, Germany +3 more
Sponsor: Vor Biopharma
Generalized Myasthenia Gravis
United States, Argentina, Australia, Belgium, Brazil +9 more
Sponsor: AstraZeneca
Non-Small Cell Lung Cancer
United States, Australia, Brazil, Canada, China +15 more
Sponsor: Bristol-Myers Squibb
Stomach Neoplasms
Japan
Sponsor: AstraZeneca
Large B-cell Lymphoma
Australia, Belgium, Brazil, Canada, China +6 more
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer · KRAS G12C Lung Cancer
United States, Argentina, Australia, Austria, Belgium +21 more
- A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHLNot Yet Recruiting
Sponsor: GlaxoSmithKline
Lymphoma, Non-Hodgkin
United States, Canada, Japan
- A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative ColitisActive Not Recruiting
Sponsor: Hoffmann-La Roche
Moderately to Severely Active Ulcerative Colitis
United States, Argentina, Australia, Austria, Belgium +25 more
- A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous PemphigoidCompleted
Sponsor: Regeneron Pharmaceuticals
Bullous Pemphigoid
United States, Australia, France, Germany, Israel +4 more
Sponsor: GlaxoSmithKline
Neoplasms, Prostate
United States, Canada, France, Japan, Spain
Sponsor: Eli Lilly and Company
Pancreatic Ductal Adenocarcinoma · Non-small Cell Lung Cancer · Colorectal Cancer
United States, Canada, China, France, Germany +4 more
Sponsor: Genentech, Inc.
Non-small Cell Lung Cancer · Gastric Cancer · Pancreatic Ductal Adenocarcinoma
United States, Australia, Brazil, Italy, Japan +4 more
- A Study of Zolbetuximab (IMAB362) in Adults With Gastric CancerActive Not Recruiting
Sponsor: Astellas Pharma Global Development, Inc.
Pharmacokinetics of Zolbetuximab · Gastric Cancer · Gastro-esophageal Junction (GEJ) Cancer · Pharmacokinetics of Oxaliplatin
United States, France, Italy, Japan, South Korea +1 more